APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,641,000 | -20.6% | 32,298 | -26.1% | 0.00% | 0.0% |
| Q4 2021 | $2,068,000 | +25.8% | 43,733 | -12.3% | 0.00% | 0.0% |
| Q3 2021 | $1,644,000 | -55.0% | 49,890 | -13.6% | 0.00% | -50.0% |
| Q2 2021 | $3,650,000 | +175.5% | 57,748 | +86.9% | 0.00% | +100.0% |
| Q1 2021 | $1,325,000 | -56.1% | 30,890 | -41.5% | 0.00% | -50.0% |
| Q4 2020 | $3,020,000 | +363.2% | 52,793 | +144.1% | 0.00% | – |
| Q3 2020 | $652,000 | -35.2% | 21,626 | -29.8% | 0.00% | -100.0% |
| Q2 2020 | $1,006,000 | +276.8% | 30,804 | +209.6% | 0.00% | – |
| Q1 2020 | $267,000 | -8.6% | 9,950 | +4.3% | 0.00% | – |
| Q4 2019 | $292,000 | +17.7% | 9,541 | -7.4% | 0.00% | – |
| Q3 2019 | $248,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |